If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

Share Price is delayed by 15 minutes
Get Live Data
31.10    -2.65 (-7.85%)
Bid:
30.70
Ask:
32.70
Spread: 2.00 (6.515%)
Market Cap: £22.83m
CAR Live PriceLast checked at - London Stock Exchange

Intraday Carclo Share Chart

AGM Statement

3 Sep 2015 07:00

RNS Number : 9155X
Carclo plc
03 September 2015
 

 

3 September 2015

 

Carclo plc

("Carclo" or the "Group")

 

AGM Statement

The board is pleased to announce that the Group has continued to perform strongly during the second quarter and trading remains in line with its expectations for the year ending 31 March 2016.

Technical Plastics has had a good start to the year. The implementation of our expansion strategy has continued with the new Chinese factory on course to commence manufacturing within the next few weeks. Our successful drive to improve operational efficiency has so far reduced the impact of the weaker Euro, helping to preserve margins in line with the board's expectations.

LED Technologies has been successful in managing the large number of new programmes that it has secured over recent years for new lighting systems from its luxury and supercar customers. Some of these are now transitioning, as expected, to prototyping and production phases. New programme wins have continued in line with our expectations. General lighting product sales have also been strong. As a whole, we currently expect the division to deliver a stronger trading performance for the year than previously anticipated.

Our Precision Engineering Aerospace business has also seen a solid performance in the first half of the financial year. We have recently experienced some weakness in the spares segment order book and, whilst this may recover in the second half, the divisional trading result is expected to be a little behind our previous expectations for the year as a whole.

Carclo Diagnostic Solutions has continued to meet its technical timelines. During the second half of the year it will increase customer and partner interactions and this will assist in providing a validation of the technology prior to moving to further phases of investment.

The Group's financing remains strong and, as expected following the investment in China, Group debt will increase slightly at the half year ending 30 September 2015, before reducing in line with expectations by the end of the financial year.

The board continues to have a strong level of confidence in the future performance of the Group.

- ENDS -

 

Enquiries:

 

Carclo plc

 

01924 268040

Chris Malley, Chief Executive

 

 

Robert Brooksbank, Finance Director

 

 

 

 

 

Peel Hunt LLP

 

0207 418 8900

Justin Jones

 

 

Jock Maxwell Macdonald

 

 

Mike Bell

 

 

 

Weber Shandwick

Nick Oborne

Tom Jenkins

 

020 7067 0000

 

Note to Editors

 

Carclo plc is a public company whose shares are quoted on the London Stock Exchange.

 

Carclo's strategy is to develop and expand its key manufacturing assets where there remain significant further opportunities to drive value. To enhance profit margins and support customers the group has been investing in lower cost regions and new technologies.

 

Approximately three fifths of revenues are derived from the supply of fine tolerance, injection moulded plastic components, mainly for medical products. The balance of revenue is derived mainly from the design and supply of specialised injection moulded LED based lighting systems to the low volume premium automotive industry.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMSSWFMEFISELU
Date   Source Headline
6th Dec 20226:29 pmRNSHolding(s) in Company - Replacement
5th Dec 20224:40 pmRNSSecond Price Monitoring Extn
5th Dec 20224:35 pmRNSPrice Monitoring Extension
30th Nov 20227:00 amRNSHalf-year Report
15th Nov 20227:05 amRNSNotice of Interim Results & Investor Presentation
15th Nov 20227:00 amRNSDirectorate Change
7th Nov 20227:00 amRNSBoard Changes
18th Oct 20227:00 amRNSTrading Update
13th Oct 20221:22 pmRNSHolding(s) in Company
6th Oct 20221:05 pmRNSAppointment of Chief Executive Officer
16th Sep 20223:16 pmRNSHolding(s) in Company
5th Sep 20227:00 amRNSTripartite Financing Agreement Secured
2nd Sep 202212:51 pmRNSHolding(s) in Company - Correction
2nd Sep 202210:37 amRNSHolding(s) in Company
1st Sep 20223:48 pmRNSHolding(s) in Company
1st Sep 20223:20 pmRNSResults of Annual General Meeting
15th Aug 20227:00 amRNSChange of Financial Adviser and Corporate Broker
4th Aug 20227:00 amRNSDirector/PDMR Shareholding
25th Jul 202211:10 amRNS2022 Annual Report and Notice of AGM
18th Jul 20224:41 pmRNSSecond Price Monitoring Extn
18th Jul 20224:35 pmRNSPrice Monitoring Extension
12th Jul 20223:56 pmRNSHolding(s) in Company
30th Jun 20227:20 amRNSNotice of Investor Presentation
30th Jun 20227:00 amRNSFinal Results
28th Jun 20227:00 amRNSNotice of Preliminary Results
7th Jun 20227:00 amRNSDirectorate Change
29th Apr 20227:00 amRNSFull Year Trading Update
9th Mar 20224:41 pmRNSSecond Price Monitoring Extn
9th Mar 20224:36 pmRNSPrice Monitoring Extension
21st Jan 20224:41 pmRNSSecond Price Monitoring Extn
21st Jan 20224:35 pmRNSPrice Monitoring Extension
18th Jan 20227:00 amRNSDirector/PDMR Shareholding
30th Dec 20214:42 pmRNSSecond Price Monitoring Extn
30th Dec 20214:36 pmRNSPrice Monitoring Extension
7th Dec 20214:41 pmRNSSecond Price Monitoring Extn
7th Dec 20214:36 pmRNSPrice Monitoring Extension
1st Dec 20212:57 pmRNSHolding(s) in Company
25th Nov 20217:00 amRNSDirector/PDMR Shareholding
24th Nov 20217:00 amRNSDirector/PDMR Shareholding
24th Nov 20217:00 amRNSDirector/PDMR Shareholding
19th Nov 20217:00 amRNSHalf Year Results
5th Nov 20217:00 amRNSNotice of Interim Results & Investor Presentation
2nd Sep 20213:08 pmRNSResults of Annual General Meeting
2nd Sep 20217:00 amRNSAGM Trading Update
6th Aug 20217:00 amRNSDirector/PDMR Shareholding
26th Jul 20212:47 pmRNS2021 Annual Report & Notice of AGM
1st Jul 20217:00 amRNSDirector/PDMR Shareholding
1st Jul 20217:00 amRNSDirector/PDMR Shareholding
30th Jun 20219:29 amRNSNotice of Investor Presentation
30th Jun 20217:00 amRNSPreliminary Results for the year ended 31 March 21

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.